- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- topaz-tx.com
- Last Round
- Venture RoundJan 2024
- Rounds
- 1
About
Topaz Therapeutics is a biopharmaceutical company developing a platform of next-generation oncology drugs through targeted therapeutics. The company leverages a proprietary platform to advance novel cancer treatments designed to improve outcomes for patients. Topaz is backed by investors including OrbiMed and Venrock, and is based in San Francisco, California.
Summary
Topaz Therapeutics is a Biotech company based in San Francisco, United States. Its most recent funding was a Venture Round round in Jan 2024. Investors include Venrock and OrbiMed.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform